Visual snow syndrome: what we know so far

被引:57
|
作者
Puledda, Francesca [1 ]
Schankin, Christoph [2 ]
Digre, Kathleen [3 ,4 ]
Goadsby, Peter J. [1 ]
机构
[1] Kings Coll London, Kings Coll Hosp, NIHR Wellcome Trust Kings Clin Res Facil, Dept Basic & Clin Neurosci,Headache Grp, London, England
[2] Univ Bern, Bern Univ Hosp, Dept Neurol, Bern, Switzerland
[3] Univ Utah, Dept Neurol, Salt Lake City, UT USA
[4] Univ Utah, Dept Ophthalmol, Salt Lake City, UT USA
关键词
palinopsia; persistent visual phenomena; photophobia; visual snow; visual static; MIGRAINE AURA; PERSISTENT; PALINOPSIA; HYPEREXCITABILITY; TOPIRAMATE; DISTINCT;
D O I
10.1097/WCO.0000000000000523
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Purpose of reviewWe provide an overview of the neurological condition known as visual snow syndrome. Patients affected by this chronic disorder suffer with a pan-field visual disturbance described as tiny flickering dots, which resemble the static noise of an untuned television.Recent findingsThe term visual snow' has only appeared in the medical literature very recently. The clinical features of the syndrome have now been reasonably described and the pathophysiology has begun to be explored. This review focuses on what is currently known about visual snow.SummaryRecent evidence suggests visual snow is a complex neurological syndrome characterized by debilitating visual symptoms. It is becoming better understood as it is systematically studied. Perhaps the most important unmet need for the condition is a sufficient understanding of it to generate and test hypotheses about treatment.
引用
收藏
页码:52 / 58
页数:7
相关论文
共 50 条
  • [1] Moebius Syndrome: What We Know So Far
    Zaidi, Syed Muhammad Hussain
    Syed, Izna Najam
    Tahir, Umair
    Noor, Tayyaba
    Choudhry, Muhammad Saad
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (02)
  • [2] What we know so far
    不详
    NEW SCIENTIST, 2021, 245 (3347) : 8 - 8
  • [3] What we know so far
    Gazzard, B
    AIDS, 1996, 10 : S3 - S7
  • [4] Vomocytosis: What we know so far
    Seoane, Paula I.
    May, Robin C.
    CELLULAR MICROBIOLOGY, 2020, 22 (02)
  • [5] Anabaenopeptins: What We Know So Far
    Monteiro, Patrick Romano
    do Amaral, Samuel Cavalcante
    Siqueira, Andrei Santos
    Xavier, Luciana Pereira
    Santos, Agenor Valadares
    TOXINS, 2021, 13 (08)
  • [6] Amyloidogenesis: What Do We Know So Far?
    Alraawi, Zeina
    Banerjee, Nayan
    Mohanty, Srujana
    Kumar, Thallapuranam Krishnaswamy Suresh
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (22)
  • [7] ASPHALTENES: WHAT DO WE KNOW SO FAR
    Al-Qasim, Abdulaziz S.
    Alasker, Mohammed
    PROCEEDINGS OF THE ASME 36TH INTERNATIONAL CONFERENCE ON OCEAN, OFFSHORE AND ARCTIC ENGINEERING, 2017, VOL 8, 2017,
  • [8] Melanoma vaccines: What we know so far
    Bystryn, Jean-Claude
    Reynolds, Sandra R.
    ONCOLOGY-NEW YORK, 2005, 19 (01): : 97 - 108
  • [9] Incremental Hemodialysis: What We Know so Far
    Soi, Vivek
    Faber, Mark D.
    Paul, Ritika
    INTERNATIONAL JOURNAL OF NEPHROLOGY AND RENOVASCULAR DISEASE, 2022, 15 : 161 - 172
  • [10] Trichotillomania: What Do We Know So Far?
    Melo, Daniel Fernandes
    Lima, Caren dos Santos
    Piraccini, Bianca Maria
    Tosti, Antonella
    SKIN APPENDAGE DISORDERS, 2022, 8 (01) : 1 - 7